RESPIRONICS INC
10-Q, EX-27, 2000-11-13
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Previous: RESPIRONICS INC, 10-Q, EX-15, 2000-11-13
Next: APPLIED VOICE RECOGNITION INC /DE/, PRE 14A, 2000-11-13



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
SEPTEMBER 30, 2000 FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-2001             JUN-30-2000
<PERIOD-START>                             JUL-01-2000             JUL-01-1999
<PERIOD-END>                               SEP-30-2000             SEP-30-1999
<CASH>                                      19,669,200              18,419,285
<SECURITIES>                                         0                       0
<RECEIVABLES>                              112,728,205             109,972,285
<ALLOWANCES>                                17,659,000              13,718,000
<INVENTORY>                                 68,474,887              60,072,356
<CURRENT-ASSETS>                           208,696,349             193,098,172
<PP&E>                                     142,546,634             115,237,448
<DEPRECIATION>                              72,485,188              52,381,231
<TOTAL-ASSETS>                             355,912,108             334,040,986
<CURRENT-LIABILITIES>                       51,057,006              45,874,716
<BONDS>                                              0                       0
                                0                       0
                                          0                       0
<COMMON>                                       332,515                 330,059
<OTHER-SE>                                 196,691,024             188,181,923
<TOTAL-LIABILITY-AND-EQUITY>               355,912,108             334,040,986
<SALES>                                     92,064,204              80,599,327
<TOTAL-REVENUES>                            92,064,204              80,599,327
<CGS>                                       48,661,952              43,436,198
<TOTAL-COSTS>                               48,661,952              48,012,550
<OTHER-EXPENSES>                            31,064,205              38,751,728
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                           2,149,124               1,425,615
<INCOME-PRETAX>                             10,484,421             (7,590,565)
<INCOME-TAX>                                 4,193,769             (3,036,226)
<INCOME-CONTINUING>                          6,290,652             (4,554,339)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                 6,290,652             (4,554,339)
<EPS-BASIC>                                       0.21                  (0.15)
<EPS-DILUTED>                                     0.21                  (0.15)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission